![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Cb-839
1. Cb-839
2. 1439399-58-2
3. Telaglenastat [usan]
4. Cb839
5. Cb 839
6. 2-(pyridin-2-yl)-n-(5-(4-(6-(2-(3-(trifluoromethoxy)phenyl)acetamido)pyridazin-3-yl)butyl)-1,3,4-thiadiazol-2-yl)acetamide
7. U6cl98glp4
8. N-[6-[4-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide
9. 2-(pyridin-2-yl)-n-(5-{4-[6-({[3-(trifluoromethoxy)phenyl]acetyl}amino)pyridazin-3-yl]butyl}-1,3,4-thiadiazol-2-yl)acetamide
10. 2-pyridineacetamide, N-(5-(4-(6-((2-(3-(trifluoromethoxy)phenyl)acetyl)amino)-3-pyridazinyl)butyl)-1,3,4-thiadiazol-2-yl)-
11. 2-(pyridin-2-yl)-n-{5-[4-(6-{2-[3-(trifluoromethoxy)phenyl]acetamido}pyridazin-3-yl)butyl]-1,3,4-thiadiazol-2-yl}acetamide
12. 2-pyridineacetamide, N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-
13. 63j
14. N-(6-(4-(5-(2-(pyridin-2-yl)acetamido)-1,3,4-thiadiazol-2-yl)butyl)pyridazin-3-yl)-2-(3-(trifluoromethoxy)phenyl)acetamide
15. N-[6-(4-{5-[2-(pyridin-2-yl)acetamido]-1,3,4-thiadiazol-2-yl}butyl)pyridazin-3-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide
16. Cb-839(telaglenastat)
17. Unii-u6cl98glp4
18. Telaglenastat [inn]
19. Telaglenastat (usan/inn)
20. Telaglenastat [who-dd]
21. Gtpl9053
22. Cb-839 [who-dd]
23. Chembl3639788
24. Schembl14987180
25. Bdbm109086
26. Hms3741e19
27. Hms3873g13
28. Amy16835
29. Bcp28287
30. Ex-a1310
31. Mfcd28167826
32. Nsc783415
33. Nsc795998
34. Nsc798057
35. S7655
36. Who 10815
37. Akos025396175
38. Zinc169698697
39. Ccg-270102
40. Cs-3393
41. Db15232
42. Nsc-783415
43. Nsc-795998
44. Nsc-798057
45. Sb17221
46. Ncgc00356145-11
47. 2-?pyridineacetamide, N-?[5-?[4-?[6-?[[2-?[3-?(trifluoromethoxy)?phenyl]?acetyl]?amino]?-?3-?pyridaz
48. Ac-31603
49. As-75090
50. Cb839; Cb 839 Pound>>telaglenastat,
51. Da-34988
52. Hy-12248
53. Ft-0767818
54. A14396
55. D11738
56. A857288
57. Us8604016, 670
58. Q27075751
59. 2-?pyridineacetamide, N-?[5-?[4-?[6-?[[2-?[3-?(trifluoromethoxy)?phenyl]?acetyl]?amino]?-?3-?pyridazinyl]?butyl]?-?1,?3,?4-?thiadiazol-?2-?yl]?-
60. N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-2-pyridineacetamide
61. N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-2-pyridineacetamide;cb-839
Molecular Weight | 571.6 g/mol |
---|---|
Molecular Formula | C26H24F3N7O3S |
XLogP3 | 3.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 12 |
Exact Mass | 571.16134331 g/mol |
Monoisotopic Mass | 571.16134331 g/mol |
Topological Polar Surface Area | 160 Ų |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 812 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |